JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Health and Consumer Protection >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/22613

Title: A feasibility study of a new method for production of U-230/TH-226 fro alpha-immunotherapy applications
Authors: ABBAS Kamel
SIMONELLI Federica
CYDZIK Izabela
KOZEMPEL JAN
APOSTOLIDIS Christos
ZIELINSKA Barbara
BRUCHERTSEIFER Frank
MORGENSTERN Alfred
Citation: NUCLEAR MEDICINE AND BIOLOGY vol. 37 no. 6 p. 677-726
Publisher: ELSEVIER SCIENCE INC
Publication Year: 2010
JRC Publication N°: JRC61211
ISSN: 0969-8051
URI: http://publications.jrc.ec.europa.eu/repository/handle/111111111/22613
DOI: 10.1016/j.nucmedbio.2010.04.161
Type: Contributions to Conferences
Appears in Collections:Institute for Health and Consumer Protection

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top